In December 2024, Eli Lilly, the US pharmaceutical giant, announced the launch of its blockbuster drug, Tirzepatide, in India in 2025
Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection
Commonly reported (mild) Mild headache, usually short-lived
As we age or face environmental stressors, our natural levels of this vital antioxidant can decline
It is the primary subject of research for reversing connective tissue senescence, treating osteoarthritis, and functionalizing scaffolds for tissue engineering
Core Molecular Action: VEGFR2 Activation and Angiogenesis At the heart of BPC-157s regenerative capability is its interaction with the vascular endothelial growth factor receptor 2 (VEGFR2)